8-K: Lifeway Foods Reports Record Q2 Sales, Strong Q3 Momentum

Lifeway Foods announced record second-quarter 2025 net sales of $53.9 million, marking nearly six years of uninterrupted growth, and projects over 20% net sales growth for the third quarter to date.

Summary

• Record net sales of $53.9 million were achieved for the second quarter ended June 30, 2025, the highest in company history.
• Net sales increased 9.7% year-over-year, and approximately 18% on a comparable basis, adjusted for a strategically exited customer relationship and a distributor shift.
• Unaudited estimated net sales for the third quarter to date through August 11, 2025, reached $26.4 million, representing an increase of over 20% compared to approximately $22 million in the same period last year.
• Gross profit margin expanded to 28.6% in Q2 2025, up from 27.0% in the prior year, and more than 460 basis points sequentially.
• Net income for Q2 2025 was $4.2 million, or $0.28 per diluted common share, compared to $3.8 million, or $0.25 per diluted share in the prior year.
• The company recorded its highest single week of gross sales in July, surpassing $5.5 million, a 66% increase over the same week in 2024.
• Lifeway was named "Processor of the Year" by Dairy Foods magazine in July, recognizing its innovation, leadership, growth, and impact on the dairy industry.
• Lifeway's Probiotic Smoothies with Collagen, the first in the category, are resonating strongly with consumers, with the Berry Blast flavor winning a 2025 Good Housekeeping Snack Award.

Sentiment

Score: 9

Explanation: The filing reports record Q2 net sales, significant gross margin expansion, double-digit EPS growth, and strong momentum continuing into Q3 with over 20% sales growth. Management expresses high confidence in future performance and category leadership, indicating robust operational execution and market demand.

Positives

• Achieved record net sales of $53.9 million in Q2 2025, marking nearly six years of uninterrupted net sales growth.
• Reported strong volume-led net sales increase of 9.7% year-over-year, and approximately 18% on a comparable basis.
• Demonstrated significant gross profit margin expansion to 28.6%, up 160 basis points year-over-year and over 460 basis points sequentially.
• Posted double-digit net income and diluted EPS growth year-over-year, with net income at $4.2 million and diluted EPS at $0.28.
• Showed accelerating momentum into Q3 with unaudited estimated net sales of $26.4 million through August 11, 2025, representing over 20% year-over-year growth.
• Recorded the highest single week of gross sales in company history in July, surpassing $5.5 million, a 66% increase over the same week in 2024.
• Received industry recognition as "Processor of the Year" by Dairy Foods magazine, highlighting leadership and innovation.
• Successfully launched innovative products like Probiotic Smoothies with Collagen, which earned a 2025 Good Housekeeping Snack Award.
• Reiterated a long-term target of $45-$50 million in Adjusted EBITDA for FY 2027, indicating confidence in future profitability.
• Expressed confidence in delivering the strongest annual sales in company history in 2025.

Risks

• Price competition.
• Decisions of customers or consumers.
• Actions of competitors.
• Changes in the pricing of commodities.
• Effects of government regulation.
• Possible delays in the introduction of new products.
• Customer acceptance of products and services.
• Uncertainty regarding proposals or other actions taken by shareholders related to the unsolicited proposal made by Danone North America PBC to acquire all of the shares of Lifeway stock that Danone does not already own.

Future Outlook

The company reiterated its long-term target of $45-$50 million in Adjusted EBITDA for fiscal year 2027 and expressed confidence in delivering the strongest annual sales in company history in 2025. Management believes Lifeway is positioned for sustained, profitable growth with record sales, expanding margins, category-leading innovation, and a scalable production platform.

Management Comments

• "This was another quarter that reinforces Lifeway's position as the undisputed leader in the kefir category." Julie Smolyansky, President and Chief Executive Officer.
• "We delivered $53.9 million in net sales, our highest quarter ever, with strong, volume-led growth across our core portfolio." Julie Smolyansky, President and Chief Executive Officer.
• "The consistency of our performance, even as we cycle past previous record highs, speaks to the strength of our brand, the loyalty of our customers, and the expanding reach of our platform." Julie Smolyansky, President and Chief Executive Officer.
• "Beyond topline growth, we expanded gross margin by 160 basis points year-over-year and more than 460 basis points sequentially, translating into double-digit net income and diluted EPS growth year-over-year." Julie Smolyansky, President and Chief Executive Officer.
• "We are executing with discipline while capturing powerful consumer tailwinds from the continued wellness boom to the surge in GLP-1 medication use as more people seek nutrient-dense, protein-rich, probiotic foods that support digestion, satiety, and natural GLP-1 hormone production." Julie Smolyansky, President and Chief Executive Officer.
• "Earning this award is a testament to our team's dedication and to the role Lifeway has played in pioneering kefir in the U.S. for nearly 40 years." Julie Smolyansky, President and Chief Executive Officer.
• "We are just getting started. With record sales, expanding margins, category-leading innovation, and a production platform ready to scale, Lifeway is positioned for sustained, profitable growth. The best is yet to come." Julie Smolyansky, President and Chief Executive Officer.

Industry Context

The company is capitalizing on growth trends in the wellness boom, the surge in GLP-1 medication use (driving demand for nutrient-dense, protein-rich, probiotic foods), and the rapidly growing $8 billion global collagen market. Lifeway is positioned as the leading U.S. supplier of kefir and fermented probiotic foods, reinforcing its leadership in the kefir category.

Comparison to Industry Standards

• Lifeway is recognized as the "undisputed leader in the kefir category" in the U.S., demonstrating market dominance.
• The company was named "Processor of the Year" by Dairy Foods magazine, the publication's highest annual honor, recognizing its innovation, leadership, growth, and impact on the dairy industry.
• Lifeway's Probiotic Smoothies with Collagen are noted as the "first in the category" to blend probiotics and collagen, indicating pioneering product development.
• The Berry Blast flavor of their Probiotic Smoothies with Collagen won a 2025 Good Housekeeping Snack Award, signifying strong consumer and industry recognition for product quality and appeal.
• The company's nearly six years of uninterrupted net sales growth demonstrates sustained outperformance within its niche, exceeding typical industry volatility.

Stakeholder Impact

• Shareholders: Positive impact due to record sales, increased profitability, strong growth momentum, and positive future outlook, potentially leading to increased share value.
• Employees: Positive impact due to company growth, industry recognition ("Processor of the Year"), and continued investment, suggesting job security and potential for growth.
• Customers: Positive impact through continued innovation (e.g., Probiotic Smoothies with Collagen) and expanding reach of products, meeting demand for nutrient-dense, protein-rich, probiotic foods.
• Suppliers: Potential for increased demand for raw materials and services due to company growth and scaling production.
• Creditors: Improved financial health and profitability enhance the company's creditworthiness.

Next Steps

• Continue to execute with discipline and capture consumer tailwinds.
• Deliver the strongest annual sales in company history in 2025.
• Work towards the long-term target of $45-$50 million in Adjusted EBITDA for FY 2027.
• Leverage the production platform ready to scale for sustained, profitable growth.

Key Dates

Recommendation

The filing demonstrates exceptional financial performance with record sales, significant margin expansion, and strong earnings growth. The momentum is clearly accelerating into the next quarter, indicating robust demand and effective strategic execution. The company's leadership in the kefir category, successful product innovation (collagen smoothies), and industry recognition (Processor of the Year) solidify its market position. The reiterated long-term Adjusted EBITDA target and confidence in achieving record annual sales in 2025 further underscore a very positive outlook. These factors collectively suggest strong potential for continued share price appreciation.

Keywords

Kefir, Probiotic, Fermented Foods, Dairy, Lifeway Foods, LWAY, Financial Results, Q2 2025, Net Sales, Gross Margin, EPS, Healthy Foods, Functional Foods, GLP-1, Farmer Cheese, Collagen